Glycaemic Responses to Cracker Snacks
This study has been completed.
Sponsor:
Mondelēz International, Inc.
Collaborator:
Reading Scientific Services Ltd.
Information provided by (Responsible Party):
Mondelēz International, Inc.
ClinicalTrials.gov Identifier:
NCT01687569
First received: September 14, 2012
Last updated: May 7, 2013
Last verified: May 2013
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 14, 2012 | ||||
| Last Updated Date | May 7, 2013 | ||||
| Start Date ICMJE | September 2012 | ||||
| Primary Completion Date | October 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Glycaemic Response(s) to cracker snacks as measured by incremental Area Under the Curve (iAUC) [ Time Frame: 120 minutes ] [ Designated as safety issue: No ] The endpoint will be the blood glucose response curve, calculated from the individual glucose measurements. Evaluated by repeated measures ANOVA on incremental AUC measured in capillary blood. |
||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01687569 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Glycaemic Responses to Cracker Snacks | ||||
| Official Title ICMJE | Effects of Added Spice Flour on Glycaemic Responses to a Cracker Snack | ||||
| Brief Summary | The purpose of this study is to determine whether added ingredient affects glycaemic responses to a cracker snack. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Basic Science |
||||
| Condition ICMJE | Glycaemic Response Measurements | ||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 27 | ||||
| Completion Date | October 2012 | ||||
| Primary Completion Date | October 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years to 55 Years | ||||
| Accepts Healthy Volunteers | Yes | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United Kingdom | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01687569 | ||||
| Other Study ID Numbers ICMJE | P12-05774 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Mondelēz International, Inc. | ||||
| Study Sponsor ICMJE | Mondelēz International, Inc. | ||||
| Collaborators ICMJE | Reading Scientific Services Ltd. | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Mondelēz International, Inc. | ||||
| Verification Date | May 2013 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||